Business Wire

CA-NETAPP

7.5.2024 14:01:35 CEST | Business Wire | Press release

Share
New Market Research Finds Up to 20% of AI Initiatives Fail Without Intelligent Data Infrastructure

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today unveiled insights from its latest report on the evolving landscape of AI in the enterprise. The IDC White Paper, sponsored by NetApp, “Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure*,” reveals the various challenges and business benefits at different levels of AI maturity and provides insights into the successful strategies adopted by leading organizations in their efforts to responsibly scale AI and GenAI workloads. By spotlighting actionable approaches, the report aims to help organizations avoid common pitfalls, ensuring that their AI initiatives are not one of the 20% that are likely to fail. The report also introduces a detailed AI maturity model developed to assess organizational progress based on their approach to AI, from AI Emergents and AI Pioneers, to AI Leaders and AI Masters

Intelligent Data Infrastructure is the Foundation of AI Success

The IDC White Paper found that:

  • AI Masters optimize their data infrastructure for transformational AI initiatives by facilitating easy access to corporate datasets with minimal preparation and designing a unified, hybrid, multicloud environment that supports various data types and access methods.
  • AI Masters have more ambitious AI goals and yet experience data-related failures including infrastructure-based data access limitations (21%), compliance limitations (16%), and insufficient data (17%).
  • AI Emergents note similar challenges but also experience budget constraints (20% Emergents vs 9% AI Masters), insufficient data for model training (26% vs 17%) and business restrictions on data access (28% vs 20%).

According to the findings, organizations need an intelligent data infrastructure in order to scale AI initiatives responsibly. Where a company falls on the AI maturity scale is determined by the level of infrastructure they have in place that will not only drive the long-term success of AI projects, but also of their associated business outcomes. Those organizations that are just beginning or have recently begun their AI journey typically have disparate data architectures or plans for a more unified architecture, while AI Leaders and AI Masters are likely already executing on a unified vision. As a result, organizations with the most AI experience are failing less.

“This IDC White Paper further solidifies that companies need intelligent data infrastructure to scale AI responsibly and boost the rate of AI initiative success,” said Jonsi Stefansson, Senior Vice President and Chief Technology Officer at NetApp. “With intelligent data infrastructure in place, companies have the flexibility to access any data, anywhere with integrated data management to ensure data security, protection, and governance and adaptive operations that can optimize performance, cost and sustainability.”

Data Infrastructure Flexibility is Crucial for Data Access and AI Initiative Success

The IDC White Paper found that:

  • 48% of AI Masters report they have instant availability of their structured data and 43% of their unstructured data, while AI Emergents have only 26% and 20% respectively.
  • AI Masters (65%) and AI Emergents (35%) reported their current data architectures can seamlessly integrate their organization’s private data with AI Cloud services.

According to the research, AI Masters know that their data architecture and infrastructure for transformational AI initiatives must offer ease of access to corporate data sets without any—or with only minor—preparation or preprocessing.

“Infrastructure decisions made during the design and planning process of AI Initiatives must factor in architecture flexibility,” said Ritu Jyoti Group Vice President, Worldwide Artificial Intelligence and Automation Research Practice, Global AI Research Lead, at IDC. “The dynamic nature of data inputs to AI and GenAI workstreams means easy access to distributed and diverse data—both structured and unstructured data sets with varying characteristics—is critical. This requires a flexible, unified approach to storage, a common control plane, and management tools that make it seamless for data scientists and developers to consume data with MLOps integrations.”

Effective Data Governance and Security Processes Drive AI Success

The IDC White Paper found that:

  • The inability for AI Emergents to progress is often due to a lack of standardized governance policies and procedures; only 8% of AI Emergents have completed and standardized these across all AI projects, compared to 38% of AI Masters.
  • While 51% of AI Masters reported they have standardized policies in place that are rigorously enforced by an independent group in their organization, only 3% of AI Emergents claim this.

The study found that effective data governance and security are crucial indicators of organizational maturity in AI initiatives. Managing data responsibly and securely remains a key issue for enterprises, because AI stakeholders often try to shortcut security processes to accelerate development. Feedback from organizations that have become more successful at delivering positive outcomes from their AI initiatives demonstrates that governance and security are not merely cost centers but vital enablers of innovation. By prioritizing security, data sovereignty, and regulatory compliance, organizations can mitigate risk in their AI and GenAI initiatives and ensure that their data engineers and scientists can focus on maximizing efficiency and productivity.

Efficient Use of Resources Important for Scaling AI Responsibly

The IDC White Paper found that:

  • 43% of AI Masters have clearly defined metrics for assessing resource efficiency when developing AI models that were completed and standardized across all AI projects compared to 9% of AI Emergents.
  • 63% of all respondents reported the need for major improvements or a complete overhaul to ensure their storage is optimized for AI and only 14% indicated they needed no improvements.

As AI workflows become increasingly integral to almost every industry, it’s critical to acknowledge the impact on compute and storage infrastructure, data and energy resources, and their associated costs. A key measure of AI maturity is the definition and implementation of metrics to assess the efficiency of resource use in the creation of AI models.

Methodology

In December of 2023 and January of 2024, IDC conducted 24 in-depth interviews and 1,220 quantitative interviews by web survey with global decision makers involved in IT operations, data science, data engineering and software development related to AI initiatives. These interviews revealed in-depth information about the state of AI initiatives today including the array of challenges, numerous business benefits, and best practices that leading organizations have taken to achieve success.

In conducting this analysis IDC has developed an AI maturity model where organizations fall into one of four maturity levels based on their current approach to AI in terms of data and storage infrastructure, data policy and governance, resource efficiency focus, and stakeholder enablement and collaboration. These maturity levels are AI Emergents, AI Pioneers, AI Leaders, and AI Masters.

*Source: IDC White Paper sponsored by NetApp, "Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure," Doc #US52048524, April 2024

Learn more at: https://www.netapp.com/pdf.html?item=/media/107000-wp-scaling-ai-initiatives.pdf

Join NetApp and a guest speaker from IDC on Wednesday, May 22 at 11am ET for the “Scaling AI Initiatives Responsibly: The Critical Role of an Intelligent Data Infrastructure” Webcast: https://www.netapp.com/forms/ai-thought-leadership-webinar/

About NetApp

NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability, and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

Additional Resources

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507078248/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye